NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
(Total Views: 281)
Posted On: 05/23/2018 8:03:36 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Granted Two New US Patents
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has been granted two new U.S. patents and expects to be granted three additional Australian patents on or before August 17, 2018. Once granted, Lexaria will have four approved patents in the U.S. and four approved patents in Australia. All eight of these patents are within the company’s first patent family, ‘Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof’, and significantly strengthen Lexaria’s intellectual property claims. The company’s growing patent portfolio now includes more than 40 patent applications or awards in over 40 countries around the world. Lexaria is currently preparing additional patent application filings for new patent families as a result of ongoing R&D programs, and it expects to announce further patent awards later this year.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has been granted two new U.S. patents and expects to be granted three additional Australian patents on or before August 17, 2018. Once granted, Lexaria will have four approved patents in the U.S. and four approved patents in Australia. All eight of these patents are within the company’s first patent family, ‘Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof’, and significantly strengthen Lexaria’s intellectual property claims. The company’s growing patent portfolio now includes more than 40 patent applications or awards in over 40 countries around the world. Lexaria is currently preparing additional patent application filings for new patent families as a result of ongoing R&D programs, and it expects to announce further patent awards later this year.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼